CannaBot aims to pair medical marijuana patients with artificial intelligence

A new smartphone app aims to connect medical marijuana patients with advice on getting the most of their prescription, through a growing database of knowledge fed by artificial intelligence. The CannaBot is being announced Friday by the suburban Philadelphia biotechnology and pharmaceutical company Affinity Bio Partners, said CEO Christina DiArcangelo Puller. The system starts out with a medical cannabis dispensary or prescribing physician signing up to use CannaBot. Then, their patients would access it through an Amazon Alexa or Google Home smart speaker. Say they've been taking a certain dosage of the cannabis compound CBD for a headache, but the pain won't go away; they could direct the speaker to bring up CannaBot then ask: What should I do?